Here is something I noticed once the article the other day
Here is something I noticed once the article the other day confirmed what happened.
Of the 7 who received ICI's. 5 who upreg still alive. 4 got tecentriq.
'At Least Two' and 'Up To' 4 who received tecentriq are still alive.
All 4 who did tencentriq took it concurrently with leron
No time delay waiting for upreg.
Does Leron/ICI combo eventually get administered simultaneously?
Why let PDL1 upreg at all?
Perhaps there is some advantage to going to work on Angiogenesis, CTC's and CAML and Macrophage Conversion etc
Also, if the regulators are so concerned about proving what drug contributed what.
Why include a VEGF inhibitor in the protocol?
"Yes, VEGF inhibitors (Vascular Endothelial Growth Factor inhibitors) are a primary type of anti-angiogenic therapy designed to fight angiogenesis, which is the process of new blood vessel formation. They block VEGF from triggering angiogenesis, thereby cutting off oxygen and nutrients to tumors and preventing their growth".
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Inseego Corp Highlights Its Participation in Major Conference Inseego Corp. (NASDAQ: INSG), a pioneer in 5G mobile and fixed wireless solutions, is preparing to showcase its latest developments at a prominent industry event. During this conference, Inseego plans to share its vision and growth strategy with investors, emphasizing the importance of its innovative solutions...
Continue Reading
SharpLink Gaming Reinforces Its Strategic ETH Holdings SharpLink Gaming, Inc. (Nasdaq: SBET), recognized as one of the leading corporate holders of Ether (ETH), has shared its financial outcomes for the recent quarter, specifically ending June 30, 2025. This news outlines SharpLink's transition towards an aggressive ETH treasury management strategy, aiming to not just...
Continue Reading
Dividend Stocks With Momentum: A Rare Combination Dividend stocks often get labeled as the safe, reliable choice for investors, but they can sometimes come off as a bit dull. They are typically associated with stable, mature companies and might lack the exciting growth stories that draw in high-flying investors. Nevertheless, they can play a crucial role in a well-rounded...
Continue Reading
Understanding the Class Action Suit Against Skyworks Solutions Investors in Skyworks Solutions, Inc. (NASDAQ: SWKS) should be aware of a significant class action lawsuit that has been initiated against the company. Pomerantz LLP has announced this crucial legal development, advocating for those who have suffered losses from their investments in the company. The Nature of...
Continue Reading
Shaking Up September by Fighting Childhood Cancer Here's a refreshing twist on a complex issue: Planet Smoothie's latest campaign against childhood cancer. They're striding alongside Alex's Lemonade Stand Foundation (ALSF) to drum up support and dollars for a cause that touches many of our hearts. With September in full swing, this partnership isn't just about refreshing,...
Continue Reading